Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

By E. R. Dorsey, R. Constantinescu, Joel P. Thompson, K. Biglan, R. Holloway, K. Kieburtz, F. Marshall, B. Ravina, G. Schifitto, A. Siderowf and 1 more. Neurology, 2007

2,406 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Complementary and alternative medicine, Neurology

View Paper: https://www.semanticscholar.org/paper/b99ba5cfc0537726097ccde8ac3e44ec5295c2cc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Ali Keshavarzian
2. R. Abbott
3. Robin M. Voigt
4. J. Kordower
5. E. Roberts
6. on behalf of the Aibl Research Group
7. J. Beck
8. C. Marras

Citations in the corpus

• Prevalence of Parkinson’s disease across North America (2018, background): “PD presents similar challenges as its prevalence in the world’s most populous nations has been projected to more than double between 2005 and 2030.(2) These estimates do not account for changes in exposures that may further contribute to increased incidence or prevalence.”
• Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease (2011, background): “Parkinson’s disease (PD) is the second most common neurodegenerative disorder of aging, and is projected to affect nearly 10 million citizens of the world’s most populous countries by 2030 [1,2].”